Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Canada Graduate Scholarship- Master's Program

EF 2014-15

Résumé
Cancer metastasis is cause of 90% of cancer deaths in patients. In addition, 30% of women overexpress human epidermal growth factor receptor 2(HER2) that leads to a more migratory and invasive form of cancer. Metastasis results from a process called EMT (epithelial-to-mesenchymal-transition) where epithelial cells located on the tumor periphery adopt a migratory phenotype that allows pieces of the tumor to break off and invade other tissues. It is an important research goal to understand the underlying processes that result in this tumor re-localization. We believe that SLK (Ste-20-like kinase), a type of serine-threonine protein kinase, is a novel target in EMT. Previous research has shown that SLK is involved in cellular migration through it's association with the focal adhesions responsible for migration, and it's increased activity following activation of the HER2 receptor. Preliminary data from our lab has shown that SLK-null tumors still maintain their epithelial markers, suggesting that SLK doesn't prevent tumor initiation, but it may play a role in tumor progression. It is our hope that SLK will be a novel therapeutic target in the prevention of breast cancer metastasis.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
331593
Name
Conway Jillian
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Canada Graduate Scholarship- Master's Program
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Emt; Invasion; Metastasis; Non-Canonical Pathway; Signal Transduction; Slk; Smads; Tgf-Beta
Abstract
Cancer metastasis is cause of 90% of cancer deaths in patients. In addition, 30% of women overexpress human epidermal growth factor receptor 2(HER2) that leads to a more migratory and invasive form of cancer. Metastasis results from a process called EMT (epithelial-to-mesenchymal-transition) where epithelial cells located on the tumor periphery adopt a migratory phenotype that allows pieces of the tumor to break off and invade other tissues. It is an important research goal to understand the underlying processes that result in this tumor re-localization. We believe that SLK (Ste-20-like kinase), a type of serine-threonine protein kinase, is a novel target in EMT. Previous research has shown that SLK is involved in cellular migration through it's association with the focal adhesions responsible for migration, and it's increased activity following activation of the HER2 receptor. Preliminary data from our lab has shown that SLK-null tumors still maintain their epithelial markers, suggesting that SLK doesn't prevent tumor initiation, but it may play a role in tumor progression. It is our hope that SLK will be a novel therapeutic target in the prevention of breast cancer metastasis.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Conway, Jillian
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~